Complement C5 Inhibition Reduces T Cell-Mediated Allograft Vasculopathy Caused by Both Alloantibody and Ischemia Reperfusion Injury in Humanized Mice-Reference-Cited by-同舟云学术

Complement C5 Inhibition Reduces T Cell-Mediated Allograft Vasculopathy Caused by Both Alloantibody and Ischemia Reperfusion Injury in Humanized Mice

Author:

Qin L.¹,Li G.¹,Kirkiles-Smith N.²,Clark P.²,Fang C.²,Wang Y.³,Yu Z.-X.³,Devore D.³,Tellides G.¹,Pober J. S.²,Jane-Wit D.⁴

Affiliation:

1. Department of Surgery; Yale School of Medicine; New Haven CT

2. Department of Immunobiology; Yale School of Medicine; New Haven CT

3. Alexion Pharmaceuticals Inc.; New Haven CT

4. Department of Cardiovascular Medicine; Yale School of Medicine; New Haven CT

Funder

National Heart, Lung, and Blood Institute

Alexion Pharmaceuticals

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Reference25 articles.

2. Cardiac allograft vasculopathy;Lee;Rev Cardiovasc Med,2011

3. Mechanisms of chronic cardiac allograft rejection;Costello;Tex Heart Inst J,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献